Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycerol is a simple polyol compound that serves as a versatile pharmaceutical agent, metabolic substrate, and humectant. In clinical practice, it is utilized as an osmotic diuretic to reduce intraocular pressure in glaucoma and intracranial pressure in neurological emergencies such as glioblastoma-associated edema. Topically, glycerol is a highly effective humectant used in emollient formulations (e.g., Miniderm) to treat dry skin and atopic dermatitis by enhancing stratum corneum hydration and barrier function. Metabolically, glycerol is a key substrate for hepatic gluconeogenesis and fatty acid esterification; recent clinical research has also identified it as a precursor for de novo glutathione synthesis in the liver, a pathway that may be impaired in patients with obesity and non-alcoholic fatty liver disease (NAFLD). It is also widely used as a component in electronic cigarette liquids and as a food additive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerol.